| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Chief Operating Officer | Ordinary Shares | 252,290 | $3,088,030 | $12.24 | 28 Jun 2024 | Direct |
| NovoCure Ltd | Chief Operating Officer | Stock Options (Right to buy) | 95,000 | $2,167,900 | $22.82 | 05 Jun 2024 | The 2020 Groenhuysen Annuity Trust |
| OptiNose, Inc. | Director | Stock Option (Right to Buy) | 0 | 21 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OPTN | OptiNose, Inc. | 21 May 2025 | 8 | $0 | 4 | Director | 21 May 2025, 09:25 |
| NVCR | NovoCure Ltd | 28 Jun 2024 | 1 | +$12,913 | 4 | Chief Operating Officer | 06 Aug 2024, 16:21 |
| OPTN | OptiNose, Inc. | 06 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:25 |
| NVCR | NovoCure Ltd | 05 Jun 2024 | 2 | $0 | 4 | Chief Operating Officer | 07 Jun 2024, 16:06 |
| NVCR | NovoCure Ltd | 01 Mar 2024 | 2 | -$53,253 | 4 | Chief Operating Officer | 05 Mar 2024, 16:09 |
| NVCR | NovoCure Ltd | 27 Feb 2024 | 4 | +$1,901,811 | 4 | Chief Operating Officer | 29 Feb 2024, 16:28 |
| NVCR | NovoCure Ltd | 01 Sep 2023 | 1 | -$6,414 | 4 | Chief Operating Officer | 05 Sep 2023, 16:24 |
| NVCR | NovoCure Ltd | 30 Jun 2023 | 1 | +$12,912 | 4 | Chief Operating Officer | 06 Jul 2023, 16:14 |
| OPTN | OptiNose, Inc. | 08 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 14:05 |
| NVCR | NovoCure Ltd | 03 Mar 2023 | 3 | -$1,952,346 | 4 | Chief Operating Officer | 07 Mar 2023, 15:51 |
| NVCR | NovoCure Ltd | 02 Mar 2023 | 3 | -$91,312 | 4 | Chief Operating Officer | 06 Mar 2023, 15:40 |
| NVCR | NovoCure Ltd | 28 Feb 2023 | 3 | +$2,606,672 | 4 | Chief Operating Officer | 02 Mar 2023, 15:49 |
| NVCR | NovoCure Ltd | 06 Jan 2023 | 1 | +$6,355 | 4 | Chief Operating Officer | 10 Jan 2023, 15:17 |
| NVCR | NovoCure Ltd | 02 Sep 2022 | 1 | -$23,395 | 4 | Chief Operating Officer | 06 Sep 2022, 17:14 |
| NVCR | NovoCure Ltd | 05 Jul 2022 | 1 | +$12,878 | 4 | Chief Operating Officer | 07 Jul 2022, 17:48 |
| OPTN | OptiNose, Inc. | 08 Jun 2022 | 1 | $0 | 4 | Director | 09 Jun 2022, 10:15 |
| NVCR | NovoCure Ltd | 05 May 2022 | 2 | $0 | 4 | Chief Operating Officer | 09 May 2022, 16:14 |
| NVCR | NovoCure Ltd | 08 Mar 2022 | 1 | -$204,902 | 4 | Chief Operating Officer | 09 Mar 2022, 15:52 |
| NVCR | NovoCure Ltd | 03 Mar 2022 | 5 | +$3,433,694 | 4 | Chief Operating Officer | 07 Mar 2022, 17:16 |
| NVCR | NovoCure Ltd | 06 Jan 2022 | 1 | +$4,786 | 4 | Chief Operating Officer | 12 Jan 2022, 16:30 |
| NVCR | NovoCure Ltd | 02 Sep 2021 | 1 | -$25,020 | 4 | Chief Operating Officer | 07 Sep 2021, 16:35 |
| NVCR | NovoCure Ltd | 10 Aug 2021 | 2 | $0 | 4 | Chief Operating Officer | 12 Aug 2021, 16:22 |
| NVCR | NovoCure Ltd | 06 Jul 2021 | 1 | +$9,050 | 4 | Chief Operating Officer | 08 Jul 2021, 17:34 |
| OPTN | OptiNose, Inc. | 09 Jun 2021 | 1 | $0 | 4 | Director | 10 Jun 2021, 15:17 |